Literature DB >> 21334334

Nuclear receptors as new perspective for the management of liver diseases.

Michael Trauner1, Emina Halilbasic.   

Abstract

Nuclear receptors (NRs) are ligand-activated transcription factors that act as sensors for a broad range of natural and synthetic ligands and regulate several key hepatic functions including bile acid homeostasis, bile secretion, lipid and glucose metabolism, as well as drug deposition. Moreover, NRs control hepatic inflammation, regeneration, fibrosis, and tumor formation. Therefore, NRs are key for understanding the pathogenesis and pathophysiology of a wide range of hepatic disorders. Finally, targeting NRs and their alterations offers exciting new perspectives for the treatment of liver diseases.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334334     DOI: 10.1053/j.gastro.2011.02.044

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Effects of statins on cholestasis: good, bad or indifferent?

Authors:  Rahul Kuver
Journal:  J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 4.029

Review 2.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

Review 3.  Pharmacological agents for NASH.

Authors:  Vlad Ratziu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-15       Impact factor: 46.802

4.  Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism.

Authors:  Rita Vik; Bodil Bjørndal; Pavol Bohov; Trond Brattelid; Asbjørn Svardal; Ottar K Nygård; Jan E Nordrehaug; Jon Skorve; Rolf K Berge
Journal:  Eur J Nutr       Date:  2014-04-23       Impact factor: 5.614

5.  Inflammation-associated upregulation of the sulfated steroid transporter Slc10a6 in mouse liver and macrophage cell lines.

Authors:  Astrid Kosters; Demesew F Abebe; Julio C Felix; Paul A Dawson; Saul J Karpen
Journal:  Hepatol Res       Date:  2015-11-19       Impact factor: 4.288

Review 6.  Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Authors:  Swetha Rudraiah; Xi Zhang; Li Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

7.  Bile acids activate YAP to promote liver carcinogenesis.

Authors:  Sayeepriyadarshini Anakk; Manoj Bhosale; Valentina A Schmidt; Randy L Johnson; Milton J Finegold; David D Moore
Journal:  Cell Rep       Date:  2013-11-21       Impact factor: 9.423

8.  Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats.

Authors:  Makoto Seo; Ikuo Inoue; Mamoru Tanaka; Noriko Matsuda; Takanari Nakano; Takuya Awata; Shigehiro Katayama; David H Alpers; Tsugikazu Komoda
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

9.  Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.

Authors:  Taro Yamashita; Azusa Kitao; Osamu Matsui; Takehiro Hayashi; Kouki Nio; Mitsumasa Kondo; Naoki Ohno; Tosiaki Miyati; Hikari Okada; Tatsuya Yamashita; Eishiro Mizukoshi; Masao Honda; Yasuni Nakanuma; Hiroyuki Takamura; Tetsuo Ohta; Yasunari Nakamoto; Masakazu Yamamoto; Tadatoshi Takayama; Shigeki Arii; XinWei Wang; Shuichi Kaneko
Journal:  Hepatology       Date:  2014-09-29       Impact factor: 17.425

Review 10.  Bile acid signaling in metabolic disease and drug therapy.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.